Short term stocks with analyst stock upgrades and upside targets

 bullish.beats
 
  bullish.beats
 
Follow  Message
 
 
 
Streaking.Winners tracks stocks achieving consecutive gains, focusing on consistent performers and market momentum to keep investors informed.
 

•  29 Nov 2025
 

•   ABL  
   
  0.00%
•   ACTU  
   
  0.00%
•   ALT  
   
  0.00%
•   CMPX  
   
  0.00%
•   FLUT  
   
  0.00%

$CMPX Compass Therapeutics offers one of the cleanest bullish technical setups here. It’s in an established uptrend, trading above all key moving averages, with RSI confirming momentum and strong analyst alignment. Speculative but technically supported, which is a powerful combo. Chance of near-term upside: 78%

$LRCX Lam Research combines strong AI-driven demand, solid fundamentals, and a confirmed uptrend. Trading well above major moving averages with healthy RSI, it offers the best blend of momentum and stability for near-term upside. Chance of near-term upside: 72%

$ALT Altimmune jumps off the screen with massive analyst-implied upside and a confirmed uptrend, trading above key moving averages with strong momentum. RSI is elevated, suggesting power but also short-term pullback risk. Still, the small market cap and improving sentiment could fuel sharp continuation moves if volume expands. Chance of near-term upside: 70%

$RAPP Rapport Therapeutics shows a firm uptrend and solid RSI strength, with enough volume to support movement despite negative EPS. Among the speculative biotech names, its structure is one of the better ones. Chance of near-term upside: 68%

$PHAR Pharming Group is in a steady uptrend above its key averages with supportive momentum. It’s not a hype play, but it is technically constructive and supported by analyst optimism. A quieter, structured mover. Chance of near-term upside: 65%

$ABL Abacus Life stands out as one of the few profitable companies on this list, trading sideways near key averages with a moderately strong RSI. If volume expands, this base could break higher. A quieter but potentially steady breakout candidate. Chance of near-term upside: 60%

$IONQ IonQ has a powerful long-term narrative in quantum computing, but shorter-term action remains choppy and in a downtrend. High volatility means big move potential, but direction is still unclear. Best suited for aggressive traders only at this stage. Chance of near-term upside: 50%

$ACTU Actuate Therapeutics shows huge headline upside, but the chart is stuck in a sideways range with low conviction from big money. Neutral RSI and lighter volume suggest hesitation. This is more of a watch and wait for breakout setup than a momentum entry right now. Chance of near-term upside: 45%

$PAYS Paysign is profitable, but price action remains in a downtrend and below key averages. Until a clear technical reversal is confirmed, upside potential is limited. More of a reversal watch than a buy-the-dip candidate. Chance of near-term upside: 40%

$FLUT Flutter Entertainment has recent analyst upgrades, but the stock is still trading in a downtrend and below important levels. Fundamentals may be turning before the chart, so patience and confirmation are key here. Chance of near-term upside: 38%

$WRD WeRide is delivering explosive revenue growth from its robotaxi expansion, but technically it’s still in a downtrend and trading below key averages. The story is strong, the chart is weak. This is a speculative reversal watch rather than a trend-following play. Chance of near-term upside: 35%

View All Headlines